{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:39:13Z","timestamp":1761766753798,"version":"3.41.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01201","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:25:20Z","timestamp":1590557120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs"],"prefix":"10.3389","volume":"11","author":[{"given":"Stefania","family":"Scala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J Med Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"L709","DOI":"10.1152\/ajplung.00341.2013","article-title":"Diverse macrophage populations mediate acute lung inflammation and resolution","volume":"306","author":"Aggarwal","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12931-018-0937-2","article-title":"Lipoxin A4 receptor agonist BML-111 induces autophagy in alveolar macrophages and protects from acute lung injury by activating MAPK signaling","volume":"19","author":"Liu","year":"2018","journal-title":"Respir Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3892\/etm.2018.5815","article-title":"Effect of TLR4\/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response","volume":"15","author":"Zhou","year":"2018","journal-title":"Exp Ther Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity."},{"key":"B14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"154895","DOI":"10.1016\/j.cyto.2019.154895","article-title":"MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines\/chemokines and elevated inflammatory innate immune response in the lower respiratory tract","volume":"126","author":"Alosaimi","year":"2020","journal-title":"Cytokine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cub.2012.11.018","article-title":"Inflammatory chemokines direct and restrict leukocyte migration within live tissues as glycan-bound gradients","volume":"22","author":"Sarris","year":"2012","journal-title":"Curr Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3760\/cma.j.issn.1001-0939.2020.03.013","article-title":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]","volume":"43","author":"Chen","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J Med Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nm.2262","article-title":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes","volume":"17","author":"Monsalvo","year":"2011","journal-title":"Nat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1128\/CVI.00081-12","article-title":"High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza","volume":"19","author":"To","year":"2012","journal-title":"Clin Vaccine Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(16)00578-X","article-title":"Acute respiratory distress syndrome","volume":"388","author":"Sweeney","year":"2016","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12688\/f1000research.20411.1","article-title":"Recent advances in the understanding and management of ARDS","author":"Peck","year":"2019","journal-title":"F1000Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0194","article-title":"Successful treatment of cytokine release syndrome with IL-6 blockade in a patient transitioning from immune-checkpoint to MEK\/BRAF inhibition: a case report and review of literature","author":"Amlani","year":"2020","journal-title":"Oncologist."},{"key":"B35","doi-asserted-by":"publisher","first-page":"E005","DOI":"10.3760\/cma.j.cn501120-20200224-00088","article-title":"[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]","volume":"36","author":"Chen","year":"2020","journal-title":"Zhonghua Shao Shang Za Zhi."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.300","article-title":"Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report","author":"Michot","year":"2020","journal-title":"Ann Oncol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217706","article-title":"Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series","author":"Aouba","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5582\/ddt.2020.03006","article-title":"Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: are we already that far?","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Discov Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ramirez","year":"2018","journal-title":"Expert Opin Drug Saf."},{"key":"B41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-018-1046-8","article-title":"Emapalumab: first global approval","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16578","article-title":"Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus","author":"Balestri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1099\/jgv.0.000512","article-title":"Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans","volume":"97","author":"To","year":"2016","journal-title":"J Gen Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/ckj\/sft071","article-title":"A single-centre retrospective study of the safety and efficacy of mycophenolate mofetil in children and adolescents with nephrotic syndrome","volume":"6","author":"Hassan","year":"2013","journal-title":"Clin Kidney J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature11824","article-title":"T-helper-1-cell cytokines drive cancer into senescence","volume":"494","author":"Braumuller","year":"2013","journal-title":"Nature."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/s0006-2952(03)00490-8","article-title":"Regulation of proliferation, survival and apoptosis by members of the TNF superfamily","volume":"66","author":"Gaur","year":"2003","journal-title":"Biochem Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.070","article-title":"Safety and efficacy of tumor necrosis factor antagonists in older patients with ulcerative colitis: patient-level pooled analysis of data from randomized trials","author":"Cheng","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-065X.2012.01099.x","article-title":"NF-kappaB and the link between inflammation and cancer","volume":"246","author":"DiDonato","year":"2012","journal-title":"Immunol Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00732-19","article-title":"Early steps in herpes simplex virus infection blocked by a proteasome inhibitor","author":"Schneider","year":"2019","journal-title":"mBio."},{"key":"B52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4049\/jimmunol.1900531","article-title":"The VR23 antitumor compound also shows strong anti-inflammatory effects in a human rheumatoid arthritis cell model and acute lung inflammation in mice","volume":"204","author":"Durkin","year":"2020","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1529-8027.2010.00248.x","article-title":"Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients","volume":"15","author":"Velasco","year":"2010","journal-title":"J Peripher Nerv Syst."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2741\/4578","article-title":"Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications","volume":"23","author":"Piao","year":"2018","journal-title":"Front Biosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000484258","article-title":"Interferon-stimulated genes as enhancers of antiviral innate immune signaling","volume":"10","author":"Crosse","year":"2018","journal-title":"J Innate Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/s41564-019-0428-3","article-title":"ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase beta-TrCP","volume":"4","author":"Guo","year":"2019","journal-title":"Nat Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"104811","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antiviral Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"eaas9332","DOI":"10.1126\/scisignal.aas9332","article-title":"PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins","volume":"11","author":"Li","year":"2018","journal-title":"Sci Signal."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jare.2020.01.008","article-title":"An overview on medicinal perspective of thiazolidine-2,4-dione: a remarkable scaffold in the treatment of type 2 diabetes","volume":"23","author":"Bansal","year":"2020","journal-title":"J Adv Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-alpha and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"Cytokine."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/db16-0152","article-title":"Selective insulin resistance and the development of cardiovascular diseases in diabetes: the 2015 edwin bierman award lecture","volume":"65","author":"King","year":"2016","journal-title":"Diabetes."},{"key":"B64","doi-asserted-by":"publisher","first-page":"109776","DOI":"10.1016\/j.mehy.2020.109776","article-title":"Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?","volume":"140","author":"Carboni","year":"2020","journal-title":"Med Hypotheses."},{"key":"B65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000168676","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis","volume":"77","author":"Aoki","year":"2009","journal-title":"Respiration."},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13578-019-0315-x","article-title":"CXCR4 knockdown prevents inflammatory cytokine expression in macrophages by suppressing activation of MAPK and NF-kappaB signaling pathways","volume":"9","author":"Tian","year":"2019","journal-title":"Cell Biosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3892\/etm.2016.3141","article-title":"CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response","volume":"11","author":"Chen","year":"2016","journal-title":"Exp Ther Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3324\/haematol.2017.184788","article-title":"Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion","volume":"103","author":"Lagresle-Peyrou","year":"2018","journal-title":"Haematologica."},{"key":"B69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.virol.2012.09.039","article-title":"Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection","volume":"435","author":"Oldstone","year":"2013","journal-title":"Virology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1212\/NXI.0000000000000753","article-title":"COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","author":"Barzegar","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s40265-017-0814-1","article-title":"Benefit-risk profile of sphingosine-1-phosphate receptor modulators in relapsing and secondary progressive multiple sclerosis","volume":"77","author":"Comi","year":"2017","journal-title":"Drugs."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:25:24Z","timestamp":1590557124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2020.01201"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01201","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"article-number":"1201"}}